Enumera Molecular, Inc. — SEC Form D Filing
Enumera Molecular, Inc. filed an SEC Form D on July 31, 2026, reporting $12.33M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 31, 2026
- Amount reported
- $12.33M
- Round stage
- Series A
- Industry
- Other Health Care
- Website
- https://enumeramolecular.com
What the company does
Securities: Equity, Offering of preferred stock and the underlying common stock issuable upon conversion of the preferred stock.. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Healthcare organizations struggle with inefficient and error-prone manual processes for managing and analyzing large volumes of molecular data, leading to delays in research, diagnostics, and treatment development.
Solution
Enumera Molecular, Inc. provides a B2B software platform that automates the enumeration, organization, and analysis of molecular data, enabling faster and more accurate insights for research, diagnostics, and therapeutic applications.
Why now
The specific timing catalyst is unclear from available information.
Source: SEC EDGAR Form D filing